2017
DOI: 10.1016/j.jopan.2017.06.073
|View full text |Cite
|
Sign up to set email alerts
|

Patient-Controlled Analgesia: Improving Patient Hand Off and Increasing Patient Safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…We therefore discuss the current state and potential developments in different areas based on a conceptual framework comprising four aspects ( Figure 1): (a) Technology: the technological system to control the administration of a pharmaceutical substance as well as all required material to deliver the drug into the human body (b) Pharmaceuticals: the pharmaceutically active substance interacting with the human body (c) Processes: the required activities to educate, to initiate, to maintain, and to conclude the therapy (d) Outcome: the overall cost-effectiveness perspective of PCA e simple reduction of PCA towards the two major components, technology and drug, does not cover the entire picture. e quality of the associated processes is a significant driver for the success or failure of the therapy [11][12][13][14]. Next to material costs and depreciation, costs incurred through actions required due to adverse events and staff costs are weighted against budgets as well as revenue potential.…”
Section: Introductionmentioning
confidence: 99%
“…We therefore discuss the current state and potential developments in different areas based on a conceptual framework comprising four aspects ( Figure 1): (a) Technology: the technological system to control the administration of a pharmaceutical substance as well as all required material to deliver the drug into the human body (b) Pharmaceuticals: the pharmaceutically active substance interacting with the human body (c) Processes: the required activities to educate, to initiate, to maintain, and to conclude the therapy (d) Outcome: the overall cost-effectiveness perspective of PCA e simple reduction of PCA towards the two major components, technology and drug, does not cover the entire picture. e quality of the associated processes is a significant driver for the success or failure of the therapy [11][12][13][14]. Next to material costs and depreciation, costs incurred through actions required due to adverse events and staff costs are weighted against budgets as well as revenue potential.…”
Section: Introductionmentioning
confidence: 99%